Published in Gene Therapy Weekly, April 28th, 1997
Researcher Jacob Odeberg and colleagues suggest, however, that other selection mechanisms may contribute to modulation of the composition of the viral population ("Variation of HCV Hypervariable Region 1 in Immunocompromised Patients," Journal of Infectious Diseases, April 1997;175:938-943).
"An isolate of hepatitis C is most...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.